The Quantum Group Announces 1st Quarter Financial Results for Fiscal Year 2009

WELLINGTON, Fla., March 24 /PRNewswire-FirstCall/ -- The Quantum Group, Inc.
(NYSE Amex: QGP) (www.QuantumMD.com) announced financial results for 1st
quarter of fiscal year 2009 and reported revenues of $7,363,593 for the
quarter ending January 31, 2009. The Company reported $2,739,475 in revenues
for the same quarter of fiscal year 2008, marking an increase of nearly 168%.
The reported revenues also reflect a 32% increase from the fourth quarter of
2008 of $5,565,009.

The Company reported a loss from operations of $3,741,495 in the first quarter
of fiscal year 2009 versus $2,794,903 from the same quarter in fiscal year
2008. This reflects an increase of 34%. The cash used from operating
activities during the first quarter of fiscal year 2009 was $1,485,090 as
compared to $1,980,099 for the first quarter of fiscal year 2008, which
represents a reduction of 25% from the first quarter of 2008. The Company
reported a loss of $3,830,581 for the quarter versus $10,689,225 for the first
quarter of fiscal year 2008, and resulted in a loss per share of $0.40 versus
$1.85 per share for the same period in 2008. The reduction in the net loss
was due to the reduction in financing costs.

Noel J. Guillama, President & CEO of The Quantum Group, commented, "We are
pleased by the continued progress of our core business operations.
Renaissance continues to expand contractual relationships and we expect to add
two national payers this year. We are in negotiations with payers for the
bulk transfer of patient lives in both Medicare and Medicaid to be managed by
Renaissance. These expansions are expected to occur after the close of open
enrollment (March 31st) and are anticipated to have an impact on upcoming
quarters. We continue to make great strides with our internal reporting and
management controls within the patient care operations. This will enable us to
continue to reduce our costs as we realize greater efficiencies and savings.
Additionally, Renaissance is exploring expansion into additional states by the
end of the calendar year."

Guillama continued, "Quarter over quarter our results demonstrate the strength
of our business model and we expect this upward trajectory to be further
enhanced by the continued deployment of our state-of-the-art healthcare
technology platform PWeR(TM) (Personal Wellness electronic Record) throughout
this year. We believe the opportunities ahead for PWeR will be of great value
to our 2,000 affiliated providers. Further, as a patient centric platform,
PWeR has the ability to connect and provide value to payers, facilities and
providers, as well as state and federal governmental agencies and is directly
in line with the objectives of the federal Stimulus Package. The platform
represents multiple potential revenue channels for Quantum and our sales and
development efforts are underway to facilitate that growth. We believe we
have the right technology platform at the right time and with a solid
foundation on which to build. Further, we believe that the results of our
efforts will be demonstrated as the year progresses and we explore expansion
to various states before the end of the calendar year."

The Stimulus Package (American Recovery and Reinvestment Act of 2009) has
designated $19.2 billion for the healthcare industry, largely to computerize
the industry and improve the quality of patient care. The Company believes
PWeR will benefit as the Stimulus provides for economic incentives for
providers and hospitals to implement and utilize electronic health record
systems.

About The Quantum Group, Inc.

The Quantum Group is an innovation-driven Healthcare Services Organization
(HSO) that provides business process solutions, service chain management,
strategic consulting and leading edge technology to the healthcare industry.

We have developed PWeR(TM), a cutting-edge, patent-pending healthcare
technology platform that we believe to be in line with President Obama's
agenda for healthcare reform. The Stimulus Package provides $19.2 billion for
the implementation of healthcare information technology to infuse
efficiencies, reduce costs and improve the quality of patient care. PWeR can
integrate all of the functions a physician/provider, hospital, clinic and
related professionals utilize in one patient-centric, web-based platform and
falls well within the economic incentives offered by the new law. We believe
we are positioned to be a catalyst for change as we take aim at the $700
billion inefficiency gap in the United States healthcare industry.

Certain statements contained in this news release, which are not based on
historical facts, are forward-looking statements as the term is defined in the
Private Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the respective
company's Securities and Exchange Commission 10-K, 10-Q, S-8, SB-2, S-1 and
8-K filings (and amendments thereto) that may cause actual results to
materially differ from projections. Forward-looking statements can be
identified by the use of words such as "expects," "plans," "will," "may,"
"anticipates," "believes," "should," "intends," "estimates" "could" and other
words of similar meaning. These statements are subject to risks and
uncertainties that cannot be predicted or quantified and, consequently, actual
results may differ materially from those expressed or implied by these
forward-looking statements. Such risk factors include, without limitation,
the ability of the Company to properly execute its business model, to raise
substantial and immediate additional capital to implement its business model,
to continue revenue growth trend in fiscal year 2009, to control patient
medical cost relative to income received, to attract and retain executive,
management and operational personnel, to continue growing its patient base, to
negotiate favorable current debt and future capital raises, to negotiate
favorable agreements with a diversified provider base and to continue to
supply the services needed by its HMO clients as well as physician clients.
We have further risk in the deployment of our technology platform, the
utilization by our clients, technical and software setbacks, cost of
development, as well as the capital to deploy it. We are subject further to
interruptions of service. Company does not undertake any obligation to
publicly update any forward-looking statements. As a result, investors should
not place undue reliance on these forward-looking statements.

FOR MORE INFORMATION, PLEASE CONTACT:
PR Financial Marketing
Jim Blackman: 713-256-0369
jim@prfmonline.com
or
Red Chip Companies
Dave Gentry: 407-644-4256
dave@redchip.com
or
The Quantum Group, Inc.
Danielle Amodio: 561.798.9800
DAmodio@QuantumMD.com

SOURCE The Quantum Group, Inc.

PR Financial Marketing, Jim Blackman: +1-713-256-0369, jim@prfmonline.com, or
Red Chip Companies, Dave Gentry: +1-407-644-4256, dave@redchip.com, or The
Quantum Group, Inc., Danielle Amodio: +1-561-798-9800, DAmodio@QuantumMD.com